MicroSteer

Endoscopic Add-on Device for the Removal of Complex Lesions

Health Tech & Life Sciences
Private

Company Overview

Snapshot

Founded in January 2023 by Ofer Pillar and Adi Strauss, MicroSteer operates with 1–10 employees. The company secured its Pre-Seed funding round in January 2023 from NGT HealthCare II.

Business overview

MicroSteer is developing a robotic system designed for the endoscopic removal of complex gastrointestinal tumors, aiming to provide an alternative to open or laparoscopic surgeries. Its core product, Phalcon-1, is positioned as the first steered polypectomy device, intended to enable endoscopists to perform safer and faster procedures. The company targets the healthcare sector, specifically providers, within the broader Health Tech & Life Sciences industry, focusing on medical devices and treatment therapeutics.

Company Intelligence Q&A

What is MicroSteer's primary focus?
MicroSteer is focused on developing an endoscopic add-on device for the removal of complex lesions, specifically a robotic system for endoscopic removal of complex GI tumors.
When was MicroSteer founded?
MicroSteer was founded in January 2023.
Who are the founders of MicroSteer?
MicroSteer was founded by Ofer Pillar and Adi Strauss.
What is MicroSteer's main product?
MicroSteer's main product is Phalcon-1, which is described as the first steered polypectomy device.